Yehoshua C. Levine

Ticagrelor or prasugrel vs. clopidogrel in combination with anticoagulation for treatment of acute coronary syndrome in patients with atrial fibrillation.

Sherif Roman, Irene Kirolos, R. Khouzam, 2019, Annals of translational medicine.

Atrial Natriuretic Peptide-initiated cGMP Pathways Regulate Vasodilator-stimulated Phosphoprotein Phosphorylation and Angiogenesis in Vascular Endothelium*

A. Lin, D. Golan, T. Michel, 2008, Journal of Biological Chemistry.

N-terminal pro-B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention ICDs.

A. Buxton, Changyu Shen, Andrew Locke, 2020, Heart rhythm.

Prevalence and outcomes of patients receiving implantable cardioverter-defibrillators for primary prevention not based on guidelines.

A. Buxton, D. Kramer, Mark K. Tuttle, 2015, The American journal of cardiology.

Atrial fibrillation during the blanking period post ablation correlates with long-term recurrence: myth vs reality

D. Linz, Yehoshua C. Levine, Ikechukwu Ifedili, 2022, Journal of interventional cardiac electrophysiology.

Vagal milieu or electrophysiologic substrate? The link between atrial fibrillation and obstructive sleep apnea

Yehoshua C. Levine, Mark R. Heckle, E. Ingram, 2022, Experimental biology and medicine.